Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Gastroenterology
Authors: Kazuki Maesaka, Hayato Hikita, Yuki Tahata, Chinatsu Nishioka, Machiko Kai, Kumiko Shirai, Kazuhiro Murai, Yuki Makino, Yoshinobu Saito, Takahiro Kodama, Kazuyoshi Ohkawa, Masanori Miyazaki, Yasutoshi Nozaki, Takayuki Yakushijin, Ryotaro Sakamori, Nobuyuki Tatsumi, Kengo Matsumoto, Hisashi Ishida, Sadaharu Iio, Takatoshi Nawa, Naruyasu Kakita, Masanori Nakahara, Atsushi Hosui, Yuichi Yoshida, Takeo Usui, Kazuho Imanaka, Yoshinori Doi, Mitsuru Sakakibara, Tetsuo Takehara
Institutions: The University of Osaka, Osaka International Cancer Institute, Kansai Rosai Hospital, Osaka Prefectural Medical Center, Osaka National Hospital, Osaka Hospital, Japan Community Healthcare Organization, Toyonaka Municipal Hospital, Ikeda Municipal Hospital, Hyogo Prefectural Nishinomiya Hospital, Kaizuka City Hospital, Minoh City Hospital, Osaka Rosai Hospital, Suita Municipal Hospital, Ashiya Municipal Hospital, Itami City Hospital, Otemae Hospital, YAO Municipal Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4415549587